CN105682676B - 利用肝细胞生长因子的两种以上的异构体的肌萎缩性侧索硬化症预防或治疗用组合物 - Google Patents
利用肝细胞生长因子的两种以上的异构体的肌萎缩性侧索硬化症预防或治疗用组合物 Download PDFInfo
- Publication number
- CN105682676B CN105682676B CN201480058075.3A CN201480058075A CN105682676B CN 105682676 B CN105682676 B CN 105682676B CN 201480058075 A CN201480058075 A CN 201480058075A CN 105682676 B CN105682676 B CN 105682676B
- Authority
- CN
- China
- Prior art keywords
- growth factor
- hepatocyte growth
- sequence
- pck
- lateral sclerosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Abstract
Description
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130126216 | 2013-10-22 | ||
KR10-2013-0126216 | 2013-10-22 | ||
PCT/KR2014/009971 WO2015060650A2 (ko) | 2013-10-22 | 2014-10-22 | 간세포 성장인자의 둘 이상의 이형체를 이용한 근위축성 측삭 경화증 예방 또는 치료용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105682676A CN105682676A (zh) | 2016-06-15 |
CN105682676B true CN105682676B (zh) | 2020-10-23 |
Family
ID=53386224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480058075.3A Active CN105682676B (zh) | 2013-10-22 | 2014-10-22 | 利用肝细胞生长因子的两种以上的异构体的肌萎缩性侧索硬化症预防或治疗用组合物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US10639351B2 (zh) |
EP (1) | EP3061457B1 (zh) |
JP (1) | JP6240337B2 (zh) |
KR (2) | KR101779775B1 (zh) |
CN (1) | CN105682676B (zh) |
AU (1) | AU2014337870B2 (zh) |
BR (1) | BR112016008267A2 (zh) |
CA (1) | CA2926607C (zh) |
ES (1) | ES2773305T3 (zh) |
HK (1) | HK1219873A1 (zh) |
MX (1) | MX2016005006A (zh) |
RU (1) | RU2639582C2 (zh) |
SG (1) | SG11201602452SA (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3046202B1 (fr) * | 2015-12-24 | 2017-12-29 | Snecma | Turboreacteur avec un moyen de reprise de poussee sur le carter inter-compresseurs |
EP3733855A4 (en) * | 2017-12-29 | 2021-03-03 | Helixmith Co., Ltd | ADENO-ASSOCIATED VIRUS (AAV) VECTOR INCLUDING A HYBRID HGF GENE INTRODUCED INTO ITS BREAST |
EP3823982A4 (en) * | 2018-07-17 | 2022-04-13 | Helixmith Co., Ltd | TREATMENT OF NEUROPATHY WITH IGF-1-ENCODING DNA CONSTRUCTS AND HGF-ENCODING DNA CONSTRUCTS |
CN110577954A (zh) * | 2019-10-12 | 2019-12-17 | 北京万福来生物技术有限责任公司 | 突变的肝细胞生长因子基因及其应用 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0255320A3 (en) | 1986-07-28 | 1989-09-06 | Genzyme Corporation | Production of proteins in myeloma cells |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
NZ232813A (en) | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
CA2022752C (en) | 1989-08-11 | 1998-07-07 | Naomi Kitamura | Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor |
US6706694B1 (en) | 1990-03-21 | 2004-03-16 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate |
DK0539590T3 (da) | 1990-07-13 | 1999-10-11 | Snow Brand Milk Products Co Ltd | Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog |
US5661133B1 (en) | 1991-11-12 | 1999-06-01 | Univ Michigan | Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein |
US7323297B1 (en) | 1992-04-03 | 2008-01-29 | The Regents Of The University Of California | Stabilized polynucleotide complexes and methods |
JP3680114B2 (ja) | 1993-09-17 | 2005-08-10 | 敏一 中村 | 脳神経障害治療剤 |
US5837676A (en) | 1993-10-18 | 1998-11-17 | Long Island Jewish Medical Center | Use of scatter factor to enhance angiogenesis |
US6498144B1 (en) | 1993-10-18 | 2002-12-24 | North Shore - Long Island Jewish Research Institute | Use of scatter factor to enhance angiogenesis |
US5652225A (en) | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
US6143714A (en) | 1994-10-24 | 2000-11-07 | Regeneron Pharmaceuticals, Inc. | Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons |
US20030148968A1 (en) | 1995-02-28 | 2003-08-07 | Hammond H. Kirk | Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
JP3927248B2 (ja) | 1995-07-11 | 2007-06-06 | 第一製薬株式会社 | Hgf凍結乾燥製剤 |
DE69634567T2 (de) | 1995-08-29 | 2006-02-16 | Anges Mg Inc., Toyonaka | Ein medikament,das hgf gen enthält |
US5830879A (en) | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
US6121246A (en) | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
JP2002515065A (ja) | 1997-05-06 | 2002-05-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 脈管形成トランスジーンのインビボ送達により心不全および心室再構成を処置するための技術および組成物 |
WO1999036103A1 (en) | 1998-01-16 | 1999-07-22 | Mcgill University | Prevention and treatment of neuropathy by hepatocyte growth factor |
JPH11246433A (ja) | 1998-03-03 | 1999-09-14 | Sumitomo Pharmaceut Co Ltd | 心筋梗塞治療剤 |
US20040228834A1 (en) | 1998-03-09 | 2004-11-18 | Jeffrey Isner | Compositions and methods for modulating vascularization |
AU766238B2 (en) | 1998-03-09 | 2003-10-09 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Compositions and methods for modulating vascularization |
US7276359B1 (en) | 1998-03-13 | 2007-10-02 | Wyeth | Polynucleotide composition, method of preparation, and use thereof |
DK1061955T3 (da) | 1998-03-13 | 2005-07-04 | Wyeth Corp | Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf |
AU765177B2 (en) | 1998-03-13 | 2003-09-11 | Wyeth | Polynucleotide composition, method of preparation, and use thereof |
AU5065599A (en) | 1998-08-05 | 2000-02-28 | Sumitomo Pharmaceuticals Company, Limited | Preparations for the administration of hepatocyte growth factor |
KR20000046969A (ko) | 1998-12-31 | 2000-07-25 | 이선경 | 이종 유전자 유래의 유전자 발현 조절요소를 포함하는 강력한전사 활성을 가진 진핵세포 발현벡더 |
CN1182874C (zh) | 1999-10-29 | 2005-01-05 | 安增子摩祺株式会社 | 糖尿病性局部缺血疾病的基因治疗制剂 |
EP1225921A1 (en) | 1999-11-05 | 2002-07-31 | The Regents of the University of California | TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
DE60134021D1 (de) | 2000-06-27 | 2008-06-26 | Anges Mg Inc | Pharmazeutische zubereitungen zur angiogenese-therapie |
CN1466463A (zh) | 2000-09-13 | 2004-01-07 | 中外制药株式会社 | 缺血性疾病治疗剂 |
US20030176347A1 (en) * | 2003-05-14 | 2003-09-18 | Toshikazu Nakamura | Remedies for amyotrophic lateral sclerosis |
JP5442173B2 (ja) | 2000-09-14 | 2014-03-12 | 敏一 中村 | 筋萎縮性側索硬化症治療剤 |
CN1150035C (zh) | 2000-12-21 | 2004-05-19 | 中国人民解放军军事医学科学院放射医学研究所 | 一种重组质粒及其在疾病防治中的应用 |
US20020172663A1 (en) | 2001-01-23 | 2002-11-21 | Maria Palasis | Localized myocardial injection method for treating ischemic myocardium |
KR100562824B1 (ko) | 2002-03-20 | 2006-03-23 | 주식회사 바이로메드 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
US20140170116A9 (en) | 2002-08-22 | 2014-06-19 | Marc S. Penn | Method of treating ischemic disorders |
WO2004060059A2 (en) | 2002-12-23 | 2004-07-22 | Vical Incorporated | Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
US20050164208A1 (en) | 2004-01-22 | 2005-07-28 | Paul Poulin | Storage of genetic information |
KR100833612B1 (ko) | 2004-12-29 | 2008-05-30 | 에프씨비파미셀 주식회사 | 간엽 간세포로부터 분화된 신경세포를 유효성분으로함유하는 신경계 질환 치료용 약학 조성물 |
WO2006121532A2 (en) | 2005-03-31 | 2006-11-16 | Mytogen, Inc. | Treatment for heart disease |
US20070212390A1 (en) | 2005-09-22 | 2007-09-13 | Ludwig Institute For Cancer Research | Protease-resistant forms of VEGF-D, method of making and method of use |
CA2628928A1 (en) | 2005-11-10 | 2007-05-24 | Receptor Biologix, Inc. | Hepatocyte growth factor intron fusion proteins |
EP2022853A4 (en) | 2006-05-17 | 2010-03-10 | Yoshiyuki Koyama | FREEZERED PRODUCT FOR THE TRANSFER OF NUCLEIC ACID, OLIGONUCLEIC ACID OR DERIVATIVES THEREOF |
WO2007142651A1 (en) | 2006-06-09 | 2007-12-13 | Caritas St. Elizabeth Medical Center Of Boston, Inc. | Methods and compositions for the treatment of neuropathy |
EP2218459B1 (en) | 2007-11-07 | 2012-02-01 | Ono Pharmaceutical Co., Ltd. | Sustained release composition containing sdf-1 |
US20090202606A1 (en) | 2008-01-25 | 2009-08-13 | Viromed Co., Ltd. | Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
AU2009234598C1 (en) | 2008-04-09 | 2012-08-23 | Viromed Co., Ltd. | Lyophilized DNA formulations for enhanced expression of plasmid DNA |
RU2413524C1 (ru) * | 2009-07-31 | 2011-03-10 | Общество с ограниченной ответственностью "КриоЦентр" | Способ лечения психических и неврологических расстройств |
WO2011079261A2 (en) | 2009-12-23 | 2011-06-30 | Curna, Inc. | Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
WO2012025925A1 (en) | 2010-08-24 | 2012-03-01 | Rappaport Family Institute For Research In The Medical Sciences | Methods of improving transplantation using sdf-1alpha |
WO2013037521A1 (en) | 2011-09-16 | 2013-03-21 | Medical Research Council | Modified hgf-1k1 polypeptide |
WO2013037520A1 (en) | 2011-09-16 | 2013-03-21 | Glaxo Group Limited | Modified hgf-1k1 polypeptide |
JP2013129661A (ja) * | 2013-02-20 | 2013-07-04 | Toshiichi Nakamura | 筋萎縮性側索硬化症治療剤 |
-
2014
- 2014-10-22 JP JP2016546724A patent/JP6240337B2/ja active Active
- 2014-10-22 CA CA2926607A patent/CA2926607C/en active Active
- 2014-10-22 EP EP14856385.1A patent/EP3061457B1/en active Active
- 2014-10-22 RU RU2016119116A patent/RU2639582C2/ru active
- 2014-10-22 US US15/030,999 patent/US10639351B2/en active Active
- 2014-10-22 MX MX2016005006A patent/MX2016005006A/es active IP Right Grant
- 2014-10-22 ES ES14856385T patent/ES2773305T3/es active Active
- 2014-10-22 BR BR112016008267A patent/BR112016008267A2/pt not_active Application Discontinuation
- 2014-10-22 CN CN201480058075.3A patent/CN105682676B/zh active Active
- 2014-10-22 KR KR1020140143377A patent/KR101779775B1/ko active IP Right Grant
- 2014-10-22 AU AU2014337870A patent/AU2014337870B2/en active Active
- 2014-10-22 SG SG11201602452SA patent/SG11201602452SA/en unknown
-
2016
- 2016-07-06 HK HK16107864.0A patent/HK1219873A1/zh unknown
-
2017
- 2017-08-31 KR KR1020170110892A patent/KR101860452B1/ko active IP Right Grant
Non-Patent Citations (7)
Title |
---|
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenicmouse model of ALS;Keiichi Kadoyama et al;《Neuroscience Research》;20091231;第65卷;第194-200页 * |
Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation;Shinsuke Kato et al;《Acta Neuropathol》;20031231;第106卷;第112-120页 * |
Hepatocyte growth factor(HGF) atteunates gliosis and motoneurnal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS;KADOYAMA K ET AL;《Neuroscience Research》;20071231;第59卷;第446-456页 * |
Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis:where do we stand?";HENRIQUES A ET AL;《Frontiers in Neuroscience》;20101231;第4卷;第1-14页 * |
Overexpression of HGF Retards Disease Progression and Prolongs Life Span in a Transgenic Mouse Model of ALS;Woong Sun et al;《The Journal of Neuroscience》;20020801;第22卷(第15期);第6537页 * |
肝细胞生长因子与神经系统疾病;杨燕等;《国外医学脑血管疾病分册》;20051231;第13卷(第12期);第933-936页 * |
肝细胞生长因子对中枢神经系统保护作用的研究进展;杨志华等;《神经损伤与功能重建》;20120131;第7卷(第1期);第59-62页 * |
Also Published As
Publication number | Publication date |
---|---|
JP2016534149A (ja) | 2016-11-04 |
BR112016008267A2 (pt) | 2017-10-03 |
US10639351B2 (en) | 2020-05-05 |
AU2014337870A1 (en) | 2016-05-05 |
KR20170104129A (ko) | 2017-09-14 |
AU2014337870B2 (en) | 2019-11-28 |
RU2016119116A (ru) | 2017-11-28 |
KR101860452B1 (ko) | 2018-05-24 |
SG11201602452SA (en) | 2016-05-30 |
RU2639582C2 (ru) | 2017-12-21 |
JP6240337B2 (ja) | 2017-11-29 |
ES2773305T3 (es) | 2020-07-10 |
EP3061457B1 (en) | 2020-01-22 |
KR101779775B1 (ko) | 2017-09-21 |
HK1219873A1 (zh) | 2017-04-21 |
EP3061457A4 (en) | 2017-06-07 |
KR20150047108A (ko) | 2015-05-04 |
EP3061457A2 (en) | 2016-08-31 |
CN105682676A (zh) | 2016-06-15 |
CA2926607A1 (en) | 2015-04-30 |
CA2926607C (en) | 2018-10-23 |
MX2016005006A (es) | 2016-07-14 |
US20160250291A1 (en) | 2016-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2024020346A (ja) | 筋疾患の治療のための改変aavカプシドポリペプチド | |
JP7263327B2 (ja) | 細胞の遺伝子修飾のための非組込みdnaベクター | |
KR20220107222A (ko) | 마이크로디스트로핀 유전자 치료 작제물 및 이의 용도 | |
TW201920679A (zh) | 眼部疾病之細胞模式及用於眼部疾病的療法 | |
CN105682676B (zh) | 利用肝细胞生长因子的两种以上的异构体的肌萎缩性侧索硬化症预防或治疗用组合物 | |
CN114174520A (zh) | 用于选择性基因调节的组合物和方法 | |
KR20170036085A (ko) | 포유동물 rpe65의 높은 아소머로하이드롤라아제 활성 돌연변이 | |
US20230044444A1 (en) | Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery | |
KR20200056428A (ko) | 변이체 RNAi | |
WO2013065913A1 (ko) | Hgf 이형체를 이용한 당뇨병성 신경병증의 유전자 치료 | |
US20190256867A1 (en) | Adeno-associated virus compositions for restoring pah gene function and methods of use thereof | |
CN116685329A (zh) | 核酸构建体及其用于治疗脊髓性肌肉萎缩症的用途 | |
WO2021230385A1 (en) | Method for treating muscular dystrophy by targeting utrophin gene | |
CN114127296A (zh) | Ube3a基因和表达盒及其应用 | |
Takeda et al. | Gene therapy for muscular dystrophies: current status and future prospects | |
JP2023539631A (ja) | Dux4遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法 | |
AU2016338565A1 (en) | Nucleic acid molecules containing spacers and methods of use thereof | |
EP4037696A2 (en) | Compositions and methods for treating alzheimer's disease | |
CN105358690B (zh) | 启动子组合物 | |
WO2015060650A2 (ko) | 간세포 성장인자의 둘 이상의 이형체를 이용한 근위축성 측삭 경화증 예방 또는 치료용 조성물 | |
WO1999036559A1 (en) | Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use | |
TW202229321A (zh) | 核酸構築體、病毒載體及病毒顆粒 | |
KR20240027748A (ko) | Rbm20 돌연변이의 게놈 편집 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1219873 Country of ref document: HK |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Seoul, South Kerean Applicant after: Hellis Messi Co., Ltd. Address before: Seoul, South Kerean Applicant before: Viromed Co., Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Han Guo Shouer Applicant after: Helismith Corporation Address before: Han Guo Shouer Applicant before: Hellis Messi Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |